DAWEX
2.12.2020 10:34:39 CET | Business Wire | Press release
Dawex , the leading data exchange technology company, today announced with Kanematsu Corporation and Japan Data Exchange Inc. the launch of JDEX , a Data Exchange Platform to create a large data trading community in Japan, spanning across industry, academia, and government, and contribute to the promotion of a cross-industry and cross-border data exchange environment. The platform, relying on Dawex Data Exchange technology and operated by Kanematsu, will serve the multinational trading corporation’s domestic and foreign network. JDEX platform enables the sourcing, exchange, sharing and commercialization of data products leveraging the platform's advanced features and capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005371/en/
Emerging as a key component of the data economy, Data Exchanges are now clearly top of the agenda of an increasing number of corporations, public institutions and governments around the world. With new initiatives on frameworks and policies multiplying everywhere such as GAIA-X in Europe, Data Trading Alliance in Japan, the World Economic Forum or the Data Exchange Association (DXA), the market is increasingly being regulated and standardized encouraging the development of trusted cross-border, cross-industry data ecosystems such as JDEX.
Awarded “Technology Pioneer ” and chosen for the Global Future Council on Data Policy by the World Economic Forum in June 2020, Dawex delivered to Kanematsu the means to deploy a powerful data exchange strategy and to create value as the orchestrator of a rich data ecosystem in Japan and abroad.
“Developing the Japan Data Exchange (JDEX) is a crucial part of Kanematsu’s data strategy that we initiated three years ago. By partnering with Dawex, we rely on the most advanced data exchange technology available today to create and support a new data community. The flexibility and sophistication of Dawex solution enables us to offer a secure and trusted environment to data providers and data acquirers and easily address their business needs.” said Mr. Masahiro Harada, Senior Executive Officer, Electronics and Devices Division at Kanematsu Corporation.
“We are very excited to see this realization with Kanematsu coming to fruition and to observe the multiplication of cross-border and cross-industry data exchange initiatives. This results from a strong commitment impulsed by the Japanese government through its regulations, and initiatives such as the Osaka Track, enabling JDEX to build a rich data community. ” stated Laurent Lafaye co-CEO of Dawex.
“Now armed with advanced data infrastructure relying on Dawex technology, and leveraging a mature governance framework, the Japan Data Exchange will unlock the full potential of a growing data ecosystem and set an example for the transition into a data-driven economy.” says Fabrice Tocco, co-CEO of Dawex. “The data marketplace will enable the development of new data models and foster innovation in a trusted and secure environment.”
About Dawex
Dawex, the leading data exchange technology company and the operator of the largest data marketplace, allows organizations to orchestrate data circulation, by sourcing and exchanging data securely, and in full compliance with regulations. Today 12,000+ organizations from 20+ sectors rely on Dawex Global Data Marketplace and Data Exchange Platform solutions to build their data exchange strategy. In 2020, Dawex is named Technology Pioneer by the World Economic Forum. Created in 2015, Dawex is a tech company with offices in France and Canada, expanding business operations to Asia and the Middle East. www.dawex.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005371/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom